Tate & Lyle | TATE - Ebitda

Stock Price
536.00
Daily Change
-9.00 -1.65%
Monthly
55.05%
Yearly
-10.82%
Q2 Forecast
526.46

Tate & Lyle reported GBP215M in EBITDA for its fiscal semester ending in December of 2025.





Ebitda Change Date
Agrana Beteiligungs EUR 20.4M 32.4M Sep/2025
Anglo-eastern Plants USD 56.97M 18.92M Dec/2024
Associated British Foods GBP 956M 136M Dec/2022
Austevoll Seafood NOK 1.98B 598M Mar/2026
Beiersdorf EUR 984M 147M Jun/2025
British American Tobacco GBP 6.02B 200M Jun/2024
Danone EUR 2.57B 116M Dec/2025
Diageo GBP 3.53B 229M Dec/2025
Givaudan CHF 778M 195M Dec/2025
Glanbia EUR 289.7M 28.1M Jan/2025
Henkel EUR 1.88B 139M Dec/2024
Imperial Brands GBP 2.5B 703M Dec/2025
International Flavors Fragrances USD 568M 260M Mar/2026
Kerry EUR 635.8M 83.6M Dec/2024
L'Oréal EUR 5.11B 489.1M Dec/2025
Nestle CHF 9.09B 594M Jun/2025
Nomad Foods EUR 92.6M 75.8M Mar/2026
Ontex EUR 123.4M 13.6M Dec/2024
Pernod Ricard EUR 2.18B 997M Dec/2024
Premier Foods GBP 140.6M 49M Mar/2025
Primary Health Properties ZAR 71.7M 700K Dec/2024
Reckitt Benckiser GBP 1.95B 708M Jun/2025
Tate & Lyle GBP 215M 22M Dec/2025
Unilever EUR 6.6B 692M Jun/2025